Biomarkers
55 researchers across 6 institutions
Research in biomarkers focuses on identifying and validating measurable indicators of biological states. Scientists investigate molecular, cellular, or physiological changes that signal normal biological processes, disease progression, or responses to therapeutic interventions. This work involves developing and applying techniques from molecular biology, genetics, and biochemistry to discover novel markers in biological samples such as blood, tissue, and urine. Areas of investigation include understanding disease mechanisms, characterizing metabolic and genetic disorders, and evaluating the pharmacological effects and toxicity of substances.
This research holds significant relevance for Arkansas. Advancements in biomarker discovery can support the state's agricultural sector by identifying markers for crop health or disease resistance. In public health, biomarker research contributes to early disease detection and personalized medicine approaches, addressing health disparities and improving outcomes for Arkansans. Furthermore, the state's unique ecological landscape may offer opportunities for discovering biomarkers related to environmental exposures and their health impacts.
This field draws upon expertise in protein structure, molecular biology techniques, and retrospective studies. Engagement spans multiple Arkansas institutions, fostering collaboration across diverse research strengths and career stages, including faculty, postdoctoral researchers, and graduate students.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Daniel W. Armstrong | UAMS | 98 | 39,657 | High Impact | |
| Shiv Srivastava | UAMS | 64 | 15,057 | High Impact | |
| Richard D. Beger | NCTR | 48 | 13,833 | High Impact | |
| James C. Fuscoe | NCTR | 47 | 13,482 | High Impact | |
| Mitchell R. McGill | UAMS | 46 | 12,417 | Grant PI High Impact | |
| Yong Zhu | UAMS | 41 | 5,411 | Grant PI High Impact | |
| V. Tiwari | University of Arkansas | 39 | 5,171 | ||
| Bill Durham | University of Arkansas | 37 | 4,367 | ||
| Wen Zhang | University of Arkansas | 34 | 3,788 | High Impact | |
| William B. Mattes | NCTR | 33 | 3,869 | High Impact | |
| Thallapuranam Krishnaswamy Suresh Kumar | University of Arkansas | 31 | 3,546 | Grant PI High Impact | |
| Jinchun Sun | NCTR | 26 | 1,825 | ||
| Varsha G. Desai | NCTR | 25 | 1,948 | ||
| Ronny Horax | University of Arkansas | 24 | 1,854 | High Impact | |
| Donald G. Catanzaro | University of Arkansas | 22 | 2,040 | High Impact | |
| Prabhat Singh Malik | UAMS | 22 | 1,909 | High Impact | |
| Adepu Kiran Kumar | UAMS | 21 | 3,212 | High Impact | |
| Brian M. Varisco | UAMS | 18 | 1,286 | ||
| Zhengyang Liu | UAMS | 17 | 835 | ||
| Susanne K. Jeffus | UAMS | 16 | 711 |
Related Research Areas
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 The University of Texas MD Anderson Cancer Center 6,946
- 2 Dana-Farber Cancer Institute 4,889
- 3 Memorial Sloan Kettering Cancer Center 4,766
- 4 Harvard University 4,164
- 5 Johns Hopkins University 3,029
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Biomarkers.